TWI921406B - 特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途 - Google Patents
特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途Info
- Publication number
- TWI921406B TWI921406B TW110142158A TW110142158A TWI921406B TW I921406 B TWI921406 B TW I921406B TW 110142158 A TW110142158 A TW 110142158A TW 110142158 A TW110142158 A TW 110142158A TW I921406 B TWI921406 B TW I921406B
- Authority
- TW
- Taiwan
- Prior art keywords
- seq
- referred
- paper
- iii
- isyc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2017927.1A GB202017927D0 (en) | 2020-11-13 | 2020-11-13 | Bicyclic peptide ligands specific for transferrin |
| GB2017927.1 | 2020-11-13 | ||
| GBGB2106903.4A GB202106903D0 (en) | 2021-05-14 | 2021-05-14 | Bicycle peptide ligands specific for transferrin |
| GB2106903.4 | 2021-05-14 | ||
| US202163261820P | 2021-09-29 | 2021-09-29 | |
| US63/261,820 | 2021-09-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202233664A TW202233664A (zh) | 2022-09-01 |
| TWI921406B true TWI921406B (zh) | 2026-04-11 |
Family
ID=81600834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110142158A TWI921406B (zh) | 2020-11-13 | 2021-11-12 | 特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11970555B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4244235A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7848202B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230107589A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116802190A (cg-RX-API-DMAC7.html) |
| AR (1) | AR126029A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021376917A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3201414A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302713A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023005624A (cg-RX-API-DMAC7.html) |
| SA (1) | SA523440745B1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI921406B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022101633A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116802190A (zh) | 2020-11-13 | 2023-09-22 | 拜斯科技术开发有限公司 | 特异于转铁蛋白受体1(TfR1)的双环肽配体 |
| GB202206431D0 (en) * | 2022-05-03 | 2022-06-15 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
| KR20260021596A (ko) * | 2023-04-05 | 2026-02-13 | 아이오니스 파마수티컬즈, 인코포레이티드 | Pln 발현을 감소시키는 화합물 및 방법 |
| EP4788689A1 (en) | 2023-10-03 | 2026-08-12 | BicycleTx Limited | Bicyclic peptide ligand complexes specific for tfr1 |
| GB202316970D0 (en) * | 2023-11-06 | 2023-12-20 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104650186A (zh) * | 2015-03-09 | 2015-05-27 | 中国药科大学 | 一种能够与TfR1特异性结合的活性肽及其应用 |
| WO2016077840A2 (en) * | 2014-11-14 | 2016-05-19 | Ossianix, Inc. | TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS |
| TW201704261A (zh) * | 2015-06-24 | 2017-02-01 | Jcr製藥股份有限公司 | 通過血腦障壁之抗人類運鐵蛋白受體抗體 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6074574B2 (ja) | 2008-02-05 | 2017-02-08 | バイシクル セラピューティクス リミテッド | 方法及び組成物 |
| GB0914110D0 (en) | 2009-08-12 | 2009-09-16 | Medical Res Council | Peptide libraries |
| GB201706477D0 (en) | 2017-04-24 | 2017-06-07 | Bicycle Therapeutics Ltd | Modification of polypeptides |
| EP3615550A1 (en) | 2017-04-27 | 2020-03-04 | BicycleTx Limited | Bicyclic peptide ligands and uses thereof |
| JP7670481B2 (ja) | 2017-08-04 | 2025-04-30 | バイスクルテクス・リミテッド | Cd137に対して特異的な二環式ペプチドリガンド |
| CA3080351A1 (en) | 2017-11-02 | 2019-05-09 | Ossianix, Inc. | Improved tfr-selective binding peptides capable of crossing the blood brain barrier |
| CA3091775A1 (en) * | 2018-02-23 | 2019-08-29 | Bicycletx Limited | Multimeric bicyclic peptide ligands |
| WO2020084305A1 (en) | 2018-10-23 | 2020-04-30 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| EP3897849A1 (en) * | 2018-12-21 | 2021-10-27 | BicycleTx Limited | Bicyclic peptide ligands specific for pd-l1 |
| GB201912320D0 (en) * | 2019-08-28 | 2019-10-09 | Bicycletx Ltd | PBP Binding Bicyclic Peptide Ligands |
| CN116802190A (zh) | 2020-11-13 | 2023-09-22 | 拜斯科技术开发有限公司 | 特异于转铁蛋白受体1(TfR1)的双环肽配体 |
-
2021
- 2021-11-12 CN CN202180089518.5A patent/CN116802190A/zh active Pending
- 2021-11-12 TW TW110142158A patent/TWI921406B/zh active
- 2021-11-12 US US17/454,665 patent/US11970555B2/en active Active
- 2021-11-12 KR KR1020237017137A patent/KR20230107589A/ko active Pending
- 2021-11-12 IL IL302713A patent/IL302713A/en unknown
- 2021-11-12 EP EP21819173.2A patent/EP4244235A1/en active Pending
- 2021-11-12 AU AU2021376917A patent/AU2021376917A1/en active Pending
- 2021-11-12 AR ARP210103150A patent/AR126029A1/es unknown
- 2021-11-12 JP JP2023528449A patent/JP7848202B2/ja active Active
- 2021-11-12 WO PCT/GB2021/052927 patent/WO2022101633A1/en not_active Ceased
- 2021-11-12 CA CA3201414A patent/CA3201414A1/en active Pending
- 2021-11-12 MX MX2023005624A patent/MX2023005624A/es unknown
-
2023
- 2023-05-11 SA SA523440745A patent/SA523440745B1/ar unknown
-
2024
- 2024-03-19 US US18/610,009 patent/US20240391959A1/en not_active Abandoned
-
2025
- 2025-04-23 US US19/187,619 patent/US20250340595A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016077840A2 (en) * | 2014-11-14 | 2016-05-19 | Ossianix, Inc. | TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS |
| CN104650186A (zh) * | 2015-03-09 | 2015-05-27 | 中国药科大学 | 一种能够与TfR1特异性结合的活性肽及其应用 |
| TW201704261A (zh) * | 2015-06-24 | 2017-02-01 | Jcr製藥股份有限公司 | 通過血腦障壁之抗人類運鐵蛋白受體抗體 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230107589A (ko) | 2023-07-17 |
| JP2023549229A (ja) | 2023-11-22 |
| IL302713A (en) | 2023-07-01 |
| AU2021376917A1 (en) | 2023-06-29 |
| AU2021376917A9 (en) | 2024-09-12 |
| CA3201414A1 (en) | 2022-05-19 |
| US20240391959A1 (en) | 2024-11-28 |
| MX2023005624A (es) | 2023-05-24 |
| WO2022101633A1 (en) | 2022-05-19 |
| AR126029A1 (es) | 2023-09-06 |
| US20220194988A1 (en) | 2022-06-23 |
| EP4244235A1 (en) | 2023-09-20 |
| SA523440745B1 (ar) | 2024-07-24 |
| JP7848202B2 (ja) | 2026-04-20 |
| TW202233664A (zh) | 2022-09-01 |
| US20250340595A1 (en) | 2025-11-06 |
| US11970555B2 (en) | 2024-04-30 |
| CN116802190A (zh) | 2023-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11970555B2 (en) | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) | |
| CN1823088B (zh) | 结合红细胞生成素受体的新肽 | |
| AU2004238870B8 (en) | Novel peptides that bind to the erythropoietin receptor | |
| US20130012685A1 (en) | Novel peptides that bind to the erythropoietin receptor | |
| JP2013173763A (ja) | エリスロポエチンレセプターペプチドの処方および使用 | |
| TW201716431A (zh) | 升糖素及glp-1共激動劑化合物 | |
| US20050203009A1 (en) | VPAC1 selective antagonists and their pharmacological methods of use | |
| JP2007534613A (ja) | レラキシンスーパーファミリーペプチド類似体 | |
| US20250276073A1 (en) | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) | |
| EA049362B1 (ru) | БИЦИКЛИЧЕСКИЕ ПЕПТИДНЫЕ ЛИГАНДЫ, СПЕЦИФИЧЕСКИЕ ДЛЯ РЕЦЕПТОРА ТРАНСФЕРРИНА 1 (TfR1) | |
| WO2025099047A1 (en) | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) | |
| Kutina et al. | Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats | |
| JP2008519858A (ja) | エリスロポエチンレセプターに結合する新規ペプチド | |
| TW202615456A (zh) | 用於肥胖症及第二型糖尿病(t2dm)的雙重及三重促效劑化合物 | |
| TW202608914A (zh) | 用於肥胖症及t2dm之人類glp1r及gipr之單促效劑及雙重促效劑化合物 | |
| JP2000290295A (ja) | N−アセチルグルコサミニルカルシトニン | |
| CN117337295A (zh) | 特异于trem2的双环肽配体 | |
| EA048412B1 (ru) | Конъюгированные миметики гепсидина | |
| JP2001199998A (ja) | カルシトニン3,26位誘導体 | |
| HK1088906B (en) | Peptides that bind to the erythropoietin receptor |